Cargando…
Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression
Recent preclinical studies have revealed a functionally important role for the drug efflux pump P‐glycoprotein (P‐gp) at the blood–brain barrier in limiting brain levels and thus antidepressant‐like activity of certain antidepressant drugs. Specifically, acute administration of P‐gp inhibitors, such...
Autores principales: | O'Brien, Fionn E., Moloney, Gerard M., Scott, Karen A., O'Connor, Richard M., Clarke, Gerard, Dinan, Timothy G., Griffin, Brendan T., Cryan, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777256/ https://www.ncbi.nlm.nih.gov/pubmed/27022464 http://dx.doi.org/10.1002/prp2.190 |
Ejemplares similares
-
Microbial regulation of microRNA expression in the amygdala and prefrontal cortex
por: Hoban, Alan E., et al.
Publicado: (2017) -
Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain
por: Moloney, Rachel D., et al.
Publicado: (2015) -
The effect of exercise interventions on inflammatory markers in major depressive disorder: protocol for a systematic review and meta-analysis
por: Grunberg, Diana, et al.
Publicado: (2022) -
Brain–Gut–Microbe Communication in Health and Disease
por: Grenham, Sue, et al.
Publicado: (2011) -
Psychotropics and the Microbiome: a Chamber of Secrets…
por: Cussotto, Sofia, et al.
Publicado: (2019)